Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : The Stock for 1999(Polymedica)PLMD(Medical Supply Co.) -- Ignore unavailable to you. Want to Upgrade?

To: Sam who wrote (1498)	7/22/1998 4:23:00 PM
From: _DB	Read Replies (1) \| Respond to of 3414

Sam & company, I spoke with the company today and came away very pleased with my investment in Polymedica. Their business is running strong, sg&a expenses are under control, their market size has the potential to grow dramatically with the addition of non-insulin dependent diabetics, they have a competitive advantage in their field, and they are extremely conservative in their financial reporting - they have reserves if needed ($5.4 million reserve for bad debts and sales allowances - 24% of total A/R). In addition, with this conference call management is recognizing the need to communicate with the investment industry, and that is a welcome change. It is also likely that at least one "name" firm will initiate coverage of Polymedica during this upcoming quarter. Also of some note is that Oscar Gruss & Son slightly raised revenue and eps amounts for the upcoming year and reiterated a $15 target, which is probably conservative. Where's the risk ... competition, but it seems like Polymedica has established that competitive advantage. The other risk, that a cure for diabetes is found, is one that I would be more than willing to lose some of my investment on. If we can find a cure for this very serious disease (ask someone who has it), it would be worth taking a loss on my tax return. But a cure does not appear to be anywhere on the horizon at this point. I welcome any other thoughts. DB P.S. I'm out of posts on the day, I'll get back tomorrow.

To: Sam who wrote (1498)	7/22/1998 6:32:00 PM
From: Arthur Radley	Read Replies (1) \| Respond to of 3414

Anytime you can get even a 1/16th uptick in such a sloppy market, I'm pleased. With Oscar G. kicking in with an update, Crittendum will certainly be close behind with a positive report. When one of the big houses gets a complete digestion of the numbers they will issue a report. The good news is that we are reaching that critical mass of being a 100million revenue company and that is when we will start getting the extensive coverage from more of the big boys. The 100 million revenue point is a major area for companies to be followed by the various funds and big money players. With Lee better understanding the PR business, it is gratifying to see the conference call. I wonder where he got the idea!(:>) There have been some excellent new contributors to the thread and it is pleasing to see the positive input of their DD. I hope some of the old timers come back and enjoy our good news. Plus, I'm happy that Dan O is going to let me sit up front in the Concorde(but not let me play with the stick). I wonder if this means that Sam will be sitting back drinking all the champagne as we cruise to Europe.(:>)or do non-stick touchers get to drink champagne in the "shot-gun" seat?